Novo Nordisk (NVO) revenue

Revenue · fiscal 2025
DKK 309.06B

Novo Nordisk (NVO) reported revenue of DKK 309.06B in fiscal 2025 (the year ended December 31, 2025). That is 6.4% higher than the DKK 290.40B of fiscal 2024. Figures as of 18 Nov 2026, 11:51 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
DKK 309.06B
Change on fiscal 2024
+6.4%
Highest on record
DKK 309.06Bfiscal 2025
Lowest on record
DKK 176.95Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in DKK. Figures, not advice.

Novo Nordisk revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was DKK 309.06B in fiscal 2025 and the lowest DKK 176.95B in fiscal 2022.

History · 4 fiscal years

Revenue by fiscal year

Novo Nordisk revenue, year by year

Novo Nordisk (NVO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025DKK 309.06B 6.4% up
2024DKK 290.40B 25.0% up
2023DKK 232.26B 31.3% up
2022DKK 176.95B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Novo Nordisk and comparable companies
CompanyRevenueFiscal year
Abbott Laboratories ABT$44.33B2025
Novo Nordisk NVODKK 309.06B2025
Pfizer PFE$62.58B2025
Danaher DHR$24.57B2025
Intuitive Surgical ISRG$10.06B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on NVO

Novo Nordisk, figure by figure

Novo Nordisk (NVO) overview: price, valuation and scorecardAll health care companies by market value

Novo Nordisk revenue: questions and answers

What is Novo Nordisk's revenue?

Novo Nordisk (NVO) reported revenue of DKK 309.06B in fiscal 2025 (the year ended December 31, 2025). That is 6.4% higher than the DKK 290.40B of fiscal 2024.

What are the highest and lowest revenue figures on record for Novo Nordisk?

Across the 4 fiscal years on record (2022–2025), the highest was DKK 309.06B in fiscal 2025 and the lowest DKK 176.95B in fiscal 2022.

How is Novo Nordisk's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Novo Nordisk it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Novo Nordisk (NVO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/revenue

Underlying data: Yahoo Finance.